TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10329815

Group type: COMPARATOR
Intervention: Inhaled albuterol 400 micrograms (low dose) after placebo
Number of subjects: 16

Group type: COMPARATOR
Intervention: Inhaled albuterol 1600 micrograms (high dose) after placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Inhaled albuterol 400 micrograms (low dose) after formoterol 12 micrograms
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Inhaled albuterol 1600 micrograms (high dose) after formoterol 12 micrograms
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Inhaled albuterol 400 micrograms (low dose) after salmeterol 50 micrograms
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Inhaled albuterol 1600 micrograms (high dose) after salmeterol 50 micrograms
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Post hoc analysis of beta2-adrenoceptor polymorphisms
Number of subjects: 16
Study: 7757335

Group type: EXPERIMENTAL
Intervention: Topical tretinoin therapy for 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 2185303

Group type: EXPERIMENTAL
Intervention: Milnacipran 100 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Milnacipran 200 mg/d
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amitriptyline 150 mg/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Milnacipran 50 mg/d
Number of subjects: 0
Study: 7033745

Group type: EXPERIMENTAL
Intervention: Active pharmacological treatment
Number of subjects: 582

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 582
Study: 31805992

Group type: EXPERIMENTAL
Intervention: Calprotectin levels at DMARD tapering/stopping
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Calprotectin predictive value for flare
Number of subjects: 161
Study: 27323323

Group type: EXPERIMENTAL
Intervention: Lateral walking training
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Backward walking training
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 26372274

Group type: EXPERIMENTAL
Intervention: 10 mg daily rosuvastatin
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 23401474

Group type: EXPERIMENTAL
Intervention: Silexan (160 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 21617837

Group type: EXPERIMENTAL
Intervention: 2 minutes of resistance training per day for 10 weeks
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: 12 minutes of resistance training per day for 10 weeks
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (weekly health information)
Number of subjects: 198
Study: 20396722

Group type: EXPERIMENTAL
Intervention: Artrofoon in combination with SCENAR therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment in combination with SCENAR therapy
Number of subjects: 0
Study: 17519319

Group type: EXPERIMENTAL
Intervention: 500 ml water
Number of subjects: 16

Group type: COMPARATOR
Intervention: isoosmotic saline
Number of subjects: 16

Group type: COMPARATOR
Intervention: 50 ml water
Number of subjects: 16
Study: 15531229

Group type: EXPERIMENTAL
Intervention: Fibrin glue sealant
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control (no fibrin glue application)
Number of subjects: 125
Study: 11442893

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 182

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 182
Study: 9761082

Group type: EXPERIMENTAL
Intervention: Invasive strategy involving cardiac catheterization within 4 to 48 hours and revascularization with angioplasty or bypass surgery if feasible
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conservative strategy, where patients are referred for catheterization only for recurrent pain at rest or provokable ischemia
Number of subjects: 0
Study: 7822629

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 10 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2900819

Group type: EXPERIMENTAL
Intervention: Esmolol (E) loading dose of 500 micrograms/kg/min for 1 min
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Esmolol (E) loading dose of 500 micrograms/kg/min for 2 min
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Esmolol (E) loading dose of 500 micrograms/kg/min for 4 min
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (5% D/W)
Number of subjects: 40
Study: 31675174

Group type: EXPERIMENTAL
Intervention: Combined model (radiomics signature + clinical‐radiological risk factors)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: 3-mm peritumoral expansion model
Number of subjects: 184

Group type: COMPARATOR
Intervention: Clinical-radiological model
Number of subjects: 184
Study: 29641212

Group type: EXPERIMENTAL
Intervention: Hippotherapy (24 sessions, twice weekly)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Pharmacotherapy
Number of subjects: 34
Study: 27543447

Group type: EXPERIMENTAL
Intervention: Amiselimod 0.1 mg
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Amiselimod 0.2 mg
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Amiselimod 0.4 mg
Number of subjects: 415

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 415
Study: 24823326

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Passive Distraction (watching a movie)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 30
Study: 22631662

Group type: EXPERIMENTAL
Intervention: Tailored telephone counseling
Number of subjects: 2065

Group type: EXPERIMENTAL
Intervention: Tailored postcard reminder after tailored telephone counseling
Number of subjects: 2065

Group type: EXPERIMENTAL
Intervention: Tailored telephone counseling after tailored postcard reminder
Number of subjects: 2065

Group type: COMPARATOR
Intervention: Reference group (no intervention)
Number of subjects: 2065

Group type: EXPERIMENTAL
Intervention: Intervention effect in ever-screened men
Number of subjects: 2065
Study: 20503809

Group type: EXPERIMENTAL
Intervention: Certified Safe Farm (CSF) intervention
Number of subjects: 185
Study: 18762864

Group type: EXPERIMENTAL
Intervention: Kefir (oral lavage and 250 ml swallowed)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.09% NaCl (oral lavage twice a day)
Number of subjects: 40
Study: 15820913

Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/day
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg/day
Number of subjects: 246

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 246
Study: 15189747

Group type: EXPERIMENTAL
Intervention: H/M (75% LP/25% NPL)
Number of subjects: 89

Group type: COMPARATOR
Intervention: LP + N (Insulin lispro + NPH)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: H/M
Number of subjects: 89

Group type: COMPARATOR
Intervention: LP + N
Number of subjects: 89
Study: 11095321

Group type: EXPERIMENTAL
Intervention: Rabeprazole 10 mg once daily
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Rabeprazole 20 mg once daily
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study: 9037573

Group type: EXPERIMENTAL
Intervention: Domperidone (30 mg/day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Cimetidine or ranitidine
Number of subjects: 46
Study: 1608985

Group type: EXPERIMENTAL
Intervention: Berlopentin (diacetyl-splenopentin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Caffeine
Number of subjects: 0
Study: 3981627

Group type: EXPERIMENTAL
Intervention: 6-week core curriculum plus additional sessions through Grades 7 and 8
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control condition (not specified)
Number of subjects: 22
Study: 3356051

Group type: EXPERIMENTAL
Intervention: Acetaminophen (20 mg.kg‐1 administered rectally)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Meperidine (1 mg.kg‐1 administered intramuscularly)
Number of subjects: 40
Study: 30779496

Group type: EXPERIMENTAL
Intervention: Pressed lithium disilicate inlays from milled wax patterns (group CIDW)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Milled lithium disilicate inlays from conventional impression (group CICAD)
Number of subjects: 30
Study: 28789647

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Occlusal splint
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Placebo laser
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (without bruxism)
Number of subjects: 76
Study: 26318269

Group type: EXPERIMENTAL
Intervention: Inpatient treatment
Number of subjects: 604

Group type: COMPARATOR
Intervention: Day hospital treatment
Number of subjects: 604
Study: 23994420

Group type: EXPERIMENTAL
Intervention: Allopurinol 600 mg/day
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 22206271

Group type: EXPERIMENTAL
Intervention: High-energy and high-protein diet (group B, n = 12, 4.2 g/kg/d protein and 150 kcal/kg/d)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High-energy and high-protein diet (group C, n = 12, 4.7 g/kg/d protein and 150 kcal/kg/d)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard preterm formula (group A, n = 8, 3.7 g/kg/d protein and 129 kcal/kg/d)
Number of subjects: 32
Study: 19269020

Group type: EXPERIMENTAL
Intervention: Celecoxib 100 mg b.i.d.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Naproxen 250 mg b.i.d.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Baseline (no treatment)
Number of subjects: 20
Study: 16481945

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation (n = 59) for 70 hours
Number of subjects: 120

Group type: COMPARATOR
Intervention: Individual physiotherapy (n = 61) for 10 hours
Number of subjects: 120
Study: 12237738

Group type: EXPERIMENTAL
Intervention: 10 mg lercanidipine
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: 20 mg lercanidipine
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (during run-in period)
Number of subjects: 25
Study: 10436254

Group type: EXPERIMENTAL
Intervention: Low-dose glyburide plus metformin (5, 7.5 or 10 mg/day glyburide and 800, 1,200 or 1,600 mg/day metformin)
Number of subjects: 40

Group type: COMPARATOR
Intervention: High-dose glyburide alone (5, 10 or 15 mg/day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Low-dose glyburide plus metformin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Routine clinical chemistry measurements, ECG, and ophthalmoscopic examinations
Number of subjects: 40
Study: 8000659

Group type: EXPERIMENTAL
Intervention: 2 g cefotetan preoperatively
Number of subjects: 136

Group type: COMPARATOR
Intervention: 2 g cefoxitin preoperatively
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: 2 g cefoxitin preoperatively followed by three postoperative doses
Number of subjects: 136
Study: 2155791

Group type: EXPERIMENTAL
Intervention: Modified RLND
Number of subjects: 235

Group type: COMPARATOR
Intervention: Radical RLND
Number of subjects: 235
Study: 513694

Group type: EXPERIMENTAL
Intervention: Hearing-impaired group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pure tone and speech ART
Number of subjects: 0
Study: 31605180

Group type: EXPERIMENTAL
Intervention: Overweight or obese BMI (≥25 kg/m2)
Number of subjects: 801900

Group type: EXPERIMENTAL
Intervention: Obesity (BMI ≥30 kg/m2)
Number of subjects: 801900

Group type: EXPERIMENTAL
Intervention: Genetically predicted BMI
Number of subjects: 801900
Study: 30105357

Group type: EXPERIMENTAL
Intervention: 76% rhodopsin bleach at 5° eccentricity
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 76% rhodopsin bleach at 12° eccentricity
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Area under the ROC curve for 76% bleach at 5°
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Area under the ROC curve for 76% bleach at 12°
Number of subjects: 26
Study: 27017895

Group type: EXPERIMENTAL
Intervention: Citrulline-malate (CM) supplementation (12 g dextrose + 8 g CM)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (PLA) (12 g dextrose)
Number of subjects: 17
Study: 23666589

Group type: EXPERIMENTAL
Intervention: 250 mg IORA vancomycin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 500 mg IORA vancomycin
Number of subjects: 30

Group type: COMPARATOR
Intervention: 1 g systemic vancomycin
Number of subjects: 30
Study: 23563461

Group type: EXPERIMENTAL
Intervention: 0.75% hyperbaric ropivacaine + 25 μg (0.5 ml) fentanyl
Number of subjects: 40

Group type: COMPARATOR
Intervention: 5 mg (l ml) hyperbaric bupivacaine + 25 μg (0.5 ml) fentanyl
Number of subjects: 40
Study: 20494434

Group type: EXPERIMENTAL
Intervention: PACT intervention
Number of subjects: 152

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 152
Study: 18179492

Group type: EXPERIMENTAL
Intervention: Activities‐specific Balance Confidence Scale (ABC)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Survey of Activities and Fear of Falling in the Elderly (SAFE)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Activities‐specific Balance Confidence Scale (ABC) and Survey of Activities and Fear of Falling in the Elderly (SAFE)
Number of subjects: 272
Study: 16639341

Group type: EXPERIMENTAL
Intervention: ESO 20 mg qd + FPV 1400 mg bid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ESO 20 mg qd + FPV 700 mg bid + RTV 100 mg bid
Number of subjects: 0

Group type: COMPARATOR
Intervention: FPV 1400 mg bid
Number of subjects: 0

Group type: COMPARATOR
Intervention: FPV 700 mg bid + RTV 100 mg bid
Number of subjects: 0
Study: 12762259

Group type: EXPERIMENTAL
Intervention: Thrombolytic treatment during the first hour
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prehospital thrombolysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thrombolytics (third-generation agents like reteplase and tenecteplase)
Number of subjects: 0
Study: 12845340

Group type: EXPERIMENTAL
Intervention: Omapatrilat
Number of subjects: 0
Study: 8657946

Group type: EXPERIMENTAL
Intervention: Gd‐EOB‐DTPA (12.5, 25, and 50 mumol per kilogram body weight)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Gd‐EOB‐DTPA
Number of subjects: 31

Group type: COMPARATOR
Intervention: Gd‐DTPA (0.1 mmol per kilogram body weight)
Number of subjects: 31
Study: 1809524

Group type: EXPERIMENTAL
Intervention: 0.4% Sn2 gel used while toothbrushing every day for three months
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: 1.1% neutral NaF gel for three months followed by twice daily rinsing with a remineralizing mouthrinse
Number of subjects: 184

Group type: COMPARATOR
Intervention: Non-compliant group
Number of subjects: 184
Study: 7104246

Group type: EXPERIMENTAL
Intervention: Progressive relaxation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: EMG biofeedback
Number of subjects: 40

Group type: COMPARATOR
Intervention: Biofeedback placebo
Number of subjects: 40
Study: 31177739

Group type: EXPERIMENTAL
Intervention: sIPV+sIPV+bOPV
Number of subjects: 1917

Group type: EXPERIMENTAL
Intervention: sIPV+wIPV+bOPV
Number of subjects: 1917

Group type: EXPERIMENTAL
Intervention: wIPV+sIPV+bOPV
Number of subjects: 1917

Group type: EXPERIMENTAL
Intervention: wIPV+wIPV+bOPV
Number of subjects: 1917
Study: 28643477

Group type: EXPERIMENTAL
Intervention: Red wine polyphenols (RWPs) 600 mg/d
Number of subjects: 29
Study: 26365326

Group type: EXPERIMENTAL
Intervention: CEE alone (0.625 mg/d)
Number of subjects: 27739

Group type: EXPERIMENTAL
Intervention: CEE + MPA (0.625 mg/d CEE and 2.5 mg/d MPA)
Number of subjects: 27739

Group type: EXPERIMENTAL
Intervention: Combined CEE and CEE + MPA
Number of subjects: 27739

Group type: EXPERIMENTAL
Intervention: CEE alone
Number of subjects: 27739

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27739
Study: 25002386

Group type: EXPERIMENTAL
Intervention: Extended vertical transseptal approach (group A)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Transseptal approach (group B)
Number of subjects: 72
Study: 22147942

Group type: EXPERIMENTAL
Intervention: irinotecan (CPT11), FU and LV (IFL)
Number of subjects: 506

Group type: COMPARATOR
Intervention: 5‐fluorouracil and leucovorin (FU/LV)
Number of subjects: 506
Study: 20565840

Group type: EXPERIMENTAL
Intervention: Patients with cervical carcinoma (CC)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Patients with CIN
Number of subjects: 37

Group type: COMPARATOR
Intervention: Healthy individuals
Number of subjects: 37
Study: 19124372

Group type: EXPERIMENTAL
Intervention: Nebulized formoterol fumarate (20 microg) inhalation solution for nebulization (FFIS)
Number of subjects: 569

Group type: COMPARATOR
Intervention: Formoterol fumarate dry powder inhalation (12 microg) (FA)
Number of subjects: 569
Study: 15679563

Group type: EXPERIMENTAL
Intervention: Topical ciprofloxacin (n = 216)
Number of subjects: 427

Group type: COMPARATOR
Intervention: Boric acid in alcohol (n = 211)
Number of subjects: 427
Study: 12854787

Group type: EXPERIMENTAL
Intervention: Conventional tapered cast posts and cores (n = 14)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: ParaPost system prefabricated gold posts with cast cores (n = 13)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: ParaPost system cast posts and cores (n = 13)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Radix‐Anchor posts (n = 10)
Number of subjects: 31
Study: 10556133

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (500 microg twice a day) for 4 weeks
Number of subjects: 13
Study: 8633829

Group type: EXPERIMENTAL
Intervention: Immediate treatment with slow‐acting antirheumatic drugs (SAARDs)
Number of subjects: 238

Group type: COMPARATOR
Intervention: Delayed introduction of treatment with slow‐acting antirheumatic drugs (SAARDs)
Number of subjects: 238
Study: 1361594

Group type: EXPERIMENTAL
Intervention: High-dose inhaled beclomethasone dipropionate (BDP) 1500 micrograms/day
Number of subjects: 143

Group type: COMPARATOR
Intervention: Low-dose inhaled beclomethasone dipropionate (BDP) 300 micrograms/day
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Both high-dose and low-dose BDP
Number of subjects: 143
Study: 6711997

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nifedipine plus low flow oxygen
Number of subjects: 6
Study: 29982658

Group type: EXPERIMENTAL
Intervention: Accelerated weight gain between birth and 5 years
Number of subjects: 2345

Group type: EXPERIMENTAL
Intervention: Accelerated weight gain in LBW children (BW < 2.5 kg)
Number of subjects: 2345

Group type: EXPERIMENTAL
Intervention: Accelerated weight gain in children with BW ≥ 2.5 kg
Number of subjects: 2345

Group type: COMPARATOR
Intervention: Birthweight (BW)
Number of subjects: 2345
Study: 30367680

Group type: EXPERIMENTAL
Intervention: Routine follow-up by an anesthesia professional at postoperative days 1 and 3
Number of subjects: 5600

Group type: COMPARATOR
Intervention: Standard care (control phase)
Number of subjects: 5600
Study: 26907728

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 25135805

Group type: EXPERIMENTAL
Intervention: Community pharmacist intervention discussing patients' beliefs about their medicines
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 200
Study: 23137805

Group type: EXPERIMENTAL
Intervention: 1mg nasal nicotine
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 20717693

Group type: EXPERIMENTAL
Intervention: Fatigue condition (F) after high-level isometric contractions (HIC) at 60% of maximal voluntary contraction
Number of subjects: 14

Group type: COMPARATOR
Intervention: No fatigue condition (NF) before high-level isometric contractions (HIC)
Number of subjects: 14
Study: 19083165

Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol instillation (PEI)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Long-acting octreotide alone (Control)
Number of subjects: 61
Study: 16087974

Group type: EXPERIMENTAL
Intervention: High PA diet (40% of energy as fat, 16.8% as PA, and 16.4% as OA; n = 21)
Number of subjects: 43

Group type: COMPARATOR
Intervention: High OA diet (40% of energy as fat, 1.7% as PA, and 31.4% as OA; n = 22)
Number of subjects: 43
Study: 12584832

Group type: EXPERIMENTAL
Intervention: Yiqi Wenyang Huoxue Lishui (YWHL) treatment
Number of subjects: 49

Group type: COMPARATOR
Intervention: Captopril (control)
Number of subjects: 49
Study: 10355617

Group type: EXPERIMENTAL
Intervention: Superbrush
Number of subjects: 36

Group type: COMPARATOR
Intervention: Elmex
Number of subjects: 36

Group type: COMPARATOR
Intervention: Braun
Number of subjects: 36
Study: 7939438

Group type: EXPERIMENTAL
Intervention: DDAVP 20 micrograms intranasally or 200 micrograms orally
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Alarm treatment
Number of subjects: 392

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392
Study: 3124648

Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 41

Group type: COMPARATOR
Intervention: Wedge biopsy
Number of subjects: 41
Study: 28285574

Group type: EXPERIMENTAL
Intervention: Virtual reality exercise program using Kinect (IG1)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Conventional exercise program using a paper booklet (IG2)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Usual care (CG)
Number of subjects: 33
Study: 28002202

Group type: EXPERIMENTAL
Intervention: HFM + BH4 (5 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: HFM alone
Number of subjects: 30
Study: 24885178

Group type: EXPERIMENTAL
Intervention: exposure to nature
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: relaxation
Number of subjects: 268

Group type: COMPARATOR
Intervention: control group (lunch break spent as usual)
Number of subjects: 268
Study: 22459264

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract EGb 761® (240 mg once daily)
Number of subjects: 410

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 410
Study: 19706018

Group type: EXPERIMENTAL
Intervention: Dorzolamide/timolol combination (DT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Timolol monotherapy
Number of subjects: 24
Study: 18757651

Group type: EXPERIMENTAL
Intervention: High-concentration inspired oxygen
Number of subjects: 143

Group type: COMPARATOR
Intervention: Low-concentration inspired oxygen
Number of subjects: 143
Study: 15933410

Group type: EXPERIMENTAL
Intervention: Education campaign by a local tractor and equipment dealership promoting ROPS and seatbelt retrofit kits for older tractors.
Number of subjects: 0
Study: 12858776

Group type: EXPERIMENTAL
Intervention: Sini decoction
Number of subjects: 63

Group type: COMPARATOR
Intervention: Isosorbide dinitrate
Number of subjects: 63